On The Cover: The hot debate over human genetic testing. As the scope and complexity of genetic testing have increased, so has the demand for oversight of genetic testing, especially the direct-to-consumer market. Within the last year, the activities of several governmental agencies have added to the uncertainty about how genetic testing should be offered and regulated. This issue of Clinical Chemistry contains Linnea Baudhuin’s interesting Perspective, which provides readers with some “food for thought” about determining the optimal approach for government regulated genetic testing. ©Image reproduced with permission from Getty Images/Photographer Joe Baker.
Clinical Chemistry is the leading forum for peer-reviewed, original research on innovative practices in today’s clinical laboratory. In addition to being the most cited journal in the field (24,297 citations in 2009), Clin Chem has the highest Impact Factor (6.263 in 2009) among journals of clinical chemistry, clinical (or anatomic) pathology, analytical chemistry, and the subspecialties, such as transfusion medicine, clinical microbiology.